Akers Biosciences, Inc. develops, manufactures and supplies point-of-care screening and testing products designed to bring health-related information to the patient or clinician. The Company's product offerings and pipeline products focus on delivering diagnostic assistance in a range of healthcare fields/specialties, including cardiology/emergency medicine, metabolism/nutrition, diabetes, respiratory diseases and infectious diseases detection, as well as for on and off-the-job alcohol safety initiatives. The Company's primary focus is the development and sale of disposable diagnostic testing devices that can be performed in minutes, to facilitate time sensitive therapeutic decisions. The Company's main products include a disposable breathalyzer test that measures the blood alcohol content of the user, a rapid test detecting the antibody causing an allergic reaction to Heparin and a disposable breathalyzer test that measures Free Radical activity in the human body.
Industry, Sector and Symbol:
- Sector: N/A
- Industry: N/A
- Sub-Industry: N/A
- Symbol: LON:AKR
- CUSIP: N/A
- Web: N/A
- Market Cap: £9.96 million
- Outstanding Shares: 8,853,000
- 50 Day Moving Avg: GBX 126.50
- 200 Day Moving Avg: GBX 137.59
- 52 Week Range: GBX 86 - GBX 255
Sales & Book Value:
- Trailing P/E Ratio: N/A
- P/E Growth: 0.00
- Annual Revenue: £2.96 million
- Price / Sales: 3.36
- Book Value: GBX 0.62 per share
- Price / Book: 1.81
- Average Volume: 2,608 shs.
Frequently Asked Questions for Akers Biosciences (LON:AKR)
What is Akers Biosciences' stock symbol?
Akers Biosciences trades on the London Stock Exchange (LON) under the ticker symbol "AKR."
Where is Akers Biosciences' stock going? Where will Akers Biosciences' stock price be in 2017?
0 brokers have issued 1-year target prices for Akers Biosciences' shares. Their forecasts range from GBX 150 to GBX 150. On average, they anticipate Akers Biosciences' share price to reach GBX 150 in the next year. View Analyst Ratings for Akers Biosciences.
Who are some of Akers Biosciences' key competitors?
Some companies that are related to Akers Biosciences include Oxford Pharmascience Group Plc (OXP), DX (Group) PLC (DX), Solo Oil PLC (SOLO), Anglo Asian Mining Plc (AAZ), Ascent Resources Plc (AST), Surgical Innovations Group Plc (SUN), Fox Marble Holdings PLC (FOX), EG Solutions plc (EGS), Iofina plc (IOF), Vmoto Limited (VMT), TP Group PLC (CRA), Kibo Mining PLC (KIBO), Surface Transforms plc (SCE), Corero Network Security PLC (CNS), Hardy Oil & Gas plc (HDY), Zanaga Iron Ore Co Ltd (ZIOC), Active Energy Group PLC (AEG) and Halosource Inc. Com (HAL).
How do I buy Akers Biosciences stock?
Shares of Akers Biosciences and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
How much does a share of Akers Biosciences stock cost?
One share of Akers Biosciences stock can currently be purchased for approximately GBX 112.50.
Consensus Ratings for Akers Biosciences (LON:AKR) (?) The ratings breakdown includes the most recent rating from each analyst that has rated the stock within the last twelve months. The ratings score is a calculation of the average number of sell, hold, buy and strong buy ratings (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). The consensus price target is a mean average of the most recent price target set by each analyst that has set a price target for the stock in the last twelve months.
|Ratings Breakdown: ||No ratings tracked in the last 12 months.|
|Consensus Rating:||N/A (Score: NaN)|
|Consensus Price Target: ||GBX 150|
Analysts' Ratings History for Akers Biosciences (LON:AKR)
(Data available from 5/28/2015 forward)
Earnings History for Akers Biosciences (LON:AKR)
No earnings announcements for this company have been tracked by MarketBeat.com
Earnings Estimates for Akers Biosciences (LON:AKR)
Current Year EPS Consensus Estimate: $-0.30 EPS
Dividend History for Akers Biosciences (LON:AKR)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Akers Biosciences (LON:AKR)
No insider trades for this company have been tracked by MarketBeat.com
Headline Trends for Akers Biosciences (LON:AKR)
Latest Headlines for Akers Biosciences (LON:AKR)
Akers Biosciences (AKR) Chart for Sunday, May, 28, 2017